NCT06439836
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06439836
Title Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Comprehensive Cancer Center RECRUITING Duarte California 91010 United States Details
UC San Diego Moores Cancer Center RECRUITING La Jolla California 92093 United States Details
UC Irvine Health/Chao Family Comprehensive Cancer Center RECRUITING Orange California 92868 United States Details
University of Miami Miller School of Medicine-Sylvester Cancer Center RECRUITING Miami Florida 33136 United States Details
Emory University Hospital/Winship Cancer Institute RECRUITING Atlanta Georgia 30322 United States Details
Mount Sinai Hospital RECRUITING New York New York 10029 United States Details
NYP/Weill Cornell Medical Center RECRUITING New York New York 10065 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field